Behçet's disease (BD) is a rare systemic vasculitis characterized by oral aphthous ulcers,
genital ulcers, ocular lesions and other systemic manifestations. BD occurs most frequently …

Behçet disease is an idiopathic, multisystem, chronic, and recurrent disease characterized
by exacerbations alternating with phases of quiescence, episodic panuveitis, and …

Several new treatment modalities with different mechanisms of action have been studied in
patients with Behçet's syndrome (BS). The aim of the current effort was to update the …

Objectives: To develop evidence-based European League Against Rheumatism (EULAR)
recommendations for the management of Behçet disease (BD) supplemented where …

Behçet's disease (BD) is a systemic vasculitis disorder of unknown etiology, characterized
by relapsing episodes of oral aphthous ulcers, genital ulcers, skin lesions and ocular …

OBJECTIVE:: Off-label use of anti-tumor necrosis factor (TNF) agents for Behçet's disease
(BD) is increasing. We evaluated published data on their efficacy and safety for patients with …

Abstract Purpose of Review To assess current management of Behcet's disease (BD).
Controversies on therapeutic approaches to different manifestations, whether conventional …

Background: There are reports of rare adverse effects of tumor necrosis factor (TNF)
inhibitors, including infections, malignancies, and induction of autoimmune conditions …

Background: Intravitreal injection (IVI) with administration of various pharmacological agents
is a mainstay of treatment in ophthalmology for endopthalmitis, viral retinitis, age-related …

Results from clinical trials of biologic anti-TNF drugs performed in the late 1990s confirmed
the biological relevance of TNF function in the pathogenesis of chronic noninfectious …